HIV type 1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China

AIDS Research and Human Retroviruses

Volumn 28, Issue 7, 2012, Pages 725-728

  Su, Qijian ^a   Liang, Hao ^b   Cen, Ping ^c   Bi, Zhiyou ^c   Zhou, Ping ^d  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Nanning Center for Disease Control and Prevention   (China)

^d Liuzhou Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LAMIVUDINE; NELFINAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; POL PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CHINA; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS GENE; VIRUS MUTATION;

ADULT; ANTI-HIV AGENTS; CHINA; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; T-LYMPHOCYTE SUBSETS;

EID: 84863213034     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0246     Document Type: Article

References (11)

1. Tee KK, Pybus OG, Li XJ, et al.: Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia. J Virol 2008; 82:9206-9215.
2. Laeyendecker O, Zhang GW, Quinn TC, et al.: Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 2005;38:356-362. (Pubitemid 40333504)
3. Hirsch MS, Brun-Vezinet F, Clotet B, et al.: Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003; 37:113-128. (Pubitemid 36836653)
4. Vandamme AM, Sonnerborg A, Ait-Khaled M, et al.: Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004;9:829-848. (Pubitemid 40040258)
5. Wensing AM, van de Vijver DA, Angarano G, et al.: Prevalence of drug-resistant hiv-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 2005;192:958-966. (Pubitemid 41266791)
6. Siepel AC, Halpern AL, Macken C, et al.: A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses 1995; 11:1413-1416.
7. Meng Z, Xing H, He X, et al.: Genetic characterization of three newly isolated CRF07-BC near full-length genomes in China. AIDS Res Hum Retroviruses 2007;23:1049-1054
8. Lu L, Jia M, Ma Y, et al.: The changing face of HIV in China. Nature 2008;455:609-611.
9. Su L, Graf M, Zhang Y, et al.: Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B) recombinant strain in China. J Virol 2000;74:11367-11376. (Pubitemid 32224007)
10. Rodenburg CM, Li Y, Trask SA, et al.: Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 2001;17:161-168. (Pubitemid 32099300)
11. McCutchan FE, Carr JK, Murphy D, et al.: Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retroviruses 2002;18:1135-1140. (Pubitemid 35191774)